Follow The Filings

Alphabet Inc.

Mountain View, CA 4 processed 13Fs on this site, 2025 Q3 to 2026 Q2

  • $99.1B
  • 28 holdings
  • 2026 Q2
  • +2367.2% QoQ
  • Top 5 98.5%

Portfolio

2026 Q2, filed 8/7/2026, top 12 of 28 holdings

Top 5 98.5%, top 10 99.5%

  1. SPCX, Space Exploration 95.0%
  2. PL, Planet Labs PBC 1.2%
  3. ASTS, Ast Spacemobile 0.8%
  4. CME, CME Group 0.8%
  5. ARM, Arm Holdings 0.7%
  6. RVMD, Revolution Medicines 0.5%
  7. Freshworks 0.2%
  8. PBLS, Parabilis Medicines 0.1%
  9. TEM, Tempus AI 0.1%
  10. GTLB, Gitlab 0.1%
  11. PATH, Uipath 0.1%
  12. LIFE, Ethos Technologies 0.1%
  13. Other 0.3%

AUM over time

2026 Q2 $99.1B +2367.2% QoQ
2025 Q3: $2.4B 2025 Q3: $2.4B
Q3 2025
2025 Q4: $2.6B, +7.1% QoQ 2025 Q4: $2.6B, +7.1% QoQ
Q4
2026 Q1: $4B, +55.7% QoQ 2026 Q1: $4B, +55.7% QoQ
Q1 2026
2026 Q2: $99.1B, +2367.2% QoQ 2026 Q2: $99.1B, +2367.2% QoQ
Q2

Book

2026 Q1 2025 Q4, filed 8 May, long equity only

Download CSV Download Excel All activity
CME, CME Group 25.63% New 3,484,020 $295.35 $1B +3,484,020 +$1B
PL, Planet Labs PBC 24.53%, was 24.42% Add +10.4% 35,248,893 $27.95 $985M +3,306,252 +$355M
ASTS, Ast Spacemobile 18.46% Hold 8,943,486 $82.87 $741M — —
RVMD, Revolution Medicines 7.97%, was 10.33% Reduce −1.6% 3,292,525 $97.25 $320M −52,577 +$54M
ARM, Arm Holdings 7.39% Hold 1,960,784 $151.28 $297M — —
Freshworks 3.24% Hold 16,206,643 $8.03 $130M — —
PATH, Uipath 1.94% Hold 7,034,337 $11.10 $78M — —
TEM, Tempus AI 1.75% Hold 1,551,102 $45.22 $70M — —
PAYP, Paypay 1.66% New 3,125,000 $21.34 $67M +3,125,000 +$67M
GTLB, Gitlab 1.47% Hold 2,724,712 $21.64 $59M — —
PRME, Prime Medicine 1.44% Hold 16,562,498 $3.48 $58M — —
LIFE, Ethos Technologies 1.05% New 3,770,156 $11.17 $42M +3,770,156 +$42M
MAZE, Maze Therapeutics 1.03% Hold 1,388,583 $29.85 $41M — —
BBOT 0.63% Hold 2,823,126 $8.95 $25M — —
Relay Therapeutics 0.39%, was 0.51% Reduce −0.3% 1,564,173 $9.95 $16M −4,580 +$2.3M
GLUE, Monte Rosa Therapeutics 0.28%, was 0.45% Reduce −8.1% 684,275 $16.45 $11M −60,673 −$424K
Vera Therapeutics 0.24% Hold 241,264 $40.23 $9.7M — —
Sana Biotechnology 0.20% Hold 2,812,500 $2.88 $8.1M — —
BEAM, Beam Therapeutics 0.19% Hold 321,604 $23.83 $7.7M — —
LYEL, Lyell Immunopharma 0.15% Hold 293,256 $20.06 $5.9M — —
OSCR, Oscar Health 0.14% Hold 481,988 $11.47 $5.5M — —
FIG, Figma 0.11% Hold 215,582 $21.14 $4.6M — —
Spero Therapeutics 0.05% Hold 889,979 $2.34 $2.1M — —
Hyperfine 0.02% Hold 898,720 $1.08 $971K — —
AUTL, Autolus Therapeutics 0.02% Hold 698,262 $1.38 $964K — —
Tenaya Therapeutics 0.02% Hold 915,705 $0.6900 $632K — —

Exits / last held

Gone since 2025 Q4, shown at their last reported size.

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
DXCM, DexCom 2.67% Exit 0 $66.37 $69M −1,036,937 −$69M
WGS, Genedx 0.11% Exit 0 $130.07 $3M −22,711 −$3M
Exact Sciences 0.09% Exit 0 $101.57 $2.4M −23,205 −$2.4M
Quince Therapeutics 0.02% Exit 0 $3.35 $634K −189,122 −$634K
FULC, Fulcrum Therapeutics 0.01% Exit 0 $11.29 $161K −14,262 −$161K
RGEN, Repligen — Exit 0 $164.49 $63K −383 −$63K

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2025 Q4. Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top. Exit opens the last-held block below.

Filings history

4 periods, with AUM normalized

Newest 13Fs
Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 28 $99.1B +2367.2% 13F-HR 8/7/2026 000165204426000073
2026 Q1 26 $4B +55.7% 13F-HR 5/8/2026 000165204426000051
2025 Q4 29 $2.6B +7.1% 13F-HR 2/13/2026 000165204426000023
2025 Q3 37 $2.4B — 13F-HR 11/7/2025 000165204425000096

About

Alphabet Inc.

4 processed 13Fs on this site, 2025 Q3 to 2026 Q2

SEC filing name
Alphabet Inc.
Location
Mountain View, CA
All SEC filings
View on sec.gov

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

  • The Essays of Warren Buffett, 8th Ed., Warren Buffett, Lawrence A. Cunningham View on Amazon
  • One Up On Wall Street (Lynch), Peter Lynch View on Amazon

More on the shelf